Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Johannes G. Ramaekers, Nadia R. P. W. Hutten, Natasha L. Mason, et al.
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 398-405
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field
Vince Polito, Paul Liknaitzky
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104706-104706
Open Access | Times Cited: 68
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Étienne Billard, Alexandre Torbey, Antonio Inserra, et al.
Cellular Signalling (2025) Vol. 127, pp. 111588-111588
Closed Access | Times Cited: 1
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Natalie Strand, Madeline Whitney, Brooks Johnson, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 1
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 461-466
Open Access | Times Cited: 97
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
European Neuropsychopharmacology (2020) Vol. 41, pp. 81-91
Open Access | Times Cited: 94
Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine
David S. Mathai, Sandeep M. Nayak, David B. Yaden, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 827-836
Closed Access | Times Cited: 30
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J. Murphy, Rachael L. Sumner, William J. Evans, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 6, pp. 511-521
Open Access | Times Cited: 27
Are psychedelics the answer to chronic pain: A review of current literature
Nina Kooijman, Tim Willegers, Anke Reuser, et al.
Pain Practice (2023) Vol. 23, Iss. 4, pp. 447-458
Open Access | Times Cited: 24
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
Conor H. Murray, Joel Frohlich, Connor J. Haggarty, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 11
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J. Murphy, Suresh Muthukumaraswamy, Harriet de Wit
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 500-511
Open Access | Times Cited: 9
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9
Microdosing psilocybin for chronic pain: a case series
Matthew Lyes, Kevin H. Yang, Joel Castellanos, et al.
Pain (2022) Vol. 164, Iss. 4, pp. 698-702
Closed Access | Times Cited: 33
Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans
Flora Moujaes, Katrin H. Preller, Jie Lisa Ji, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 12, pp. 1061-1070
Open Access | Times Cited: 31
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study
Mauro Cavarra, Natasha L. Mason, Kim P. C. Kuypers, et al.
European Journal of Pain (2023) Vol. 28, Iss. 1, pp. 153-165
Open Access | Times Cited: 17
Keeping the promise: a critique of the current state of microdosing research
Rotem Petranker, Thomas Anderson, Emily C. Fewster, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome
Erin E. Mauney, Franklin King, Helen Burton Murray, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes
Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz, et al.
Neuropharmacology (2025), pp. 110402-110402
Closed Access
IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain
Eda Köşeli, Belle Buzzi, Torin Honaker, et al.
Pharmacological Research (2025) Vol. 215, pp. 107699-107699
Open Access
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
Friederike Holze, Matthias E. Liechti, Nadia R. P. W. Hutten, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 658-666
Open Access | Times Cited: 39
New Paradigms of Old Psychedelics in Schizophrenia
Danish Mahmood, Sattam Khulaif Alenezi, Md Jamir Anwar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 640-640
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top